Pre-exposure prophylaxis to HIV/AIDS: situational analysis after 03 years of availability in the Unified Health System (SUS)
DOI:
https://doi.org/10.33448/rsd-v11i4.27356Keywords:
HIV; Pre-Exposure Prophylaxis; Acquired Immunodeficiency Syndrome; Anti-HIV Agents.Abstract
To assess adherence to pre-exposure prophylaxis (PrEP) to HIV after 3 years of implementation in the Unified Health System (SUS). Ecological, quantitative study, carried out in 2021, in Brazil. Data on HIV PrEP were collected in the monitoring panel provided by the Ministry of Health – Federal Government. The variables studied were type of population, age group, education, race/color; number of dispensations in Brazil from January 2018 to February 2021, number of health services offering PrEP, discontinuation of PrEP, number of new users per month, number of active users per month and sexual habits. Data were tabulated in excel and descriptive statistical analysis was performed for all variables, the chi-square test to verify the association between the variables "discontinuity of PrEP" and "type of key population" and the binomial test of two proportions to compare sexual habits in the first and last consultations. Most of the population is gay or men who have sex with men (82.6%), age group between 30 and 39 years old (51%), white or yellow color (57.2%), 12 years or more of schooling (71%). 42% of subjects discontinued treatment at some point. There was a statistically significant association between the variables “discontinuity of PrEP” and “type of key population”, and a decrease in condom use and in the number of sexual partners between the first and last consultations. Although adherence to the method is increasing, discontinuity in treatment among users is high, which makes success in effectiveness difficult.
References
Anderson, P. L., Kiser, J. J., Gardner, E. M., Rower, J. E., Meditz, A., & Grant, R. M. (2011). Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. The Journal of Antimicrobial Chemotherapy, 66(2), 240–250. https://doi.org/10.1093/jac/dkq447
Bagagli, B. P. (2017). Orientação sexual na identidade de gênero a partir da crítica da heterossexualidade e cisgeneridade como normas. Letras Escreve, 7(1), 137-164. http://dx.doi.org/10.18468/letras.2017v7n1.p137-164
Bezerra, E. O., Pereira, M. L. D., Chaves, A. C. P., & Monteiro, P. V. (2015). Representações sociais de adolescentes acerca da relação sexual e do uso de preservativos. Revista Gaúcha de Enfermagem, 36(1), 84-91. http://dx.doi.org/10.1590/1983-144
Martins, E. R. C., Medeiros, A. S., Oliveira, K. L., Fassarella, L. G., Moraes, P. C., & Spíndola, T. (2020). Vulnerability of young men and their health needs. Escola Anna Nery, 24(1), e20190203. https://doi.org/10.1590/2177-9465-EAN-2019-0203
Souza, M. V. L., Silva, R. R., Oliveira, M. C. P., Silva, L. A., Silva, M. V. G., Vargas, D., Hipólito, R. L., Souza, M. G. G., Silveira, M. L. F. G., Mesquita, L. M. F., Araújo, M. S., Ignácio, L. P., Fontes, T. V., Alencar, Ícaro F., Souza, D. A. C., Oliveira, J. V. E., Neves, M. P., Pereira, A. V., Soares Filho, M. O., & Dutra, V. C. A. (2021). Access to PrEP by cisgender mens and transsexual person: a qualitative study. Research, Society and Development, 10(1), e44310111843. https://doi.org/10.33448/rsd-v10i1.11843
Grangeiro, A., Ferraz, D., Calazans, G., Zucchi, E. M., & Díaz-Bermúdez, X. P. (2015). O efeito dos métodos preventivos na redução do risco de infecção pelo HIV nas relações sexuais e seu potencial impacto em âmbito populacional: uma revisão da literatura. Revista Brasileira de Epidemiologia, 18 Suppl 1, 43-62. https://doi.org/10.1590/1809-4503201500050005
Zucchi, E. M., Grangeiro, A., Ferraz, D., Pinheiro, T. F., Alencar, T., Ferguson, L., Estevam, D. L., Munhoz, R., & Equipe do Estudo Combina! (2018). Da evidência à ação: desafios do Sistema Único de Saúde para ofertar a profilaxia pré-exposição sexual (PrEP) ao HIV às pessoas em maior vulnerabilidade. Cadernos de Saúde Pública, 34(7), e00206617. https://doi.org/10.1590/0102-311X00206617
Brasil. (2018). Protocolos clínicos e diretrizes terapêuticas para profilaxia pré-exposição (PrEP) de risco à infecção pelo HIV. Brasília: Ministério da Saúde. http://www.aids.gov.br/pt-br/pub/2017/protocolo-clinico-e-diretrizes-terapeuticas-para-profilaxia-pre-exposicao-prep-de-risco.
Brasil. (2012). Política Brasileira de enfrentamento da AIDS: resultados, avanços e perspectivas. Brasília: Ministério da Saúde. https://bvsms.saude.gov.br/bvs/publicacoes/politica_brasileira_enfrentamento_aids_2012.pdf.
Brasil. (2021). Profilaxia pré-exposição (PrEP). http://www.aids.gov.br/pt-br/publico-geral/prevencao-combinada/profilaxia-pre-exposicao-prep#:~:text=A%20PrEP%20%C3%A9%20a%20combina%C3%A7%C3%A3o,se%20espalhe%20em%20seu%20corpo.
Brasil. (2020). Boletim Epidemiológico HIV/Aids 2020. http://www.aids.gov.br/pt-br/pub/2020/boletim-epidemiologico-hivaids-2020.
Chang, L. W., Serwadda, D., Quinn, T. C., Wawer, M. J., Gray, R. H., & Reynolds, S. J. (2013). Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. The Lancet Infectious Diseases, 13(1), 65–76. https://doi.org/10.1016/S1473-3099(12)70273-6
Kippax, S. & Stephenson, N. (2012). Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. American Journal of Public Health, 102(5), 789–799. https://doi.org/10.2105/AJPH.2011.300594
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Santa Maria: Universidade Federal de Santa Maria. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_%20Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Brasil. (2021). Painel PrEP. http://www.aids.gov.br/pt-br/painel-prep
Brasil. (2017). Portaria nº 21, de 25 de maio de 2017. Torna pública a decisão de incorporar o tenofovir associado a entricitabina (TDF/FTC 300/200mg) como profilaxia pré-exposição (PrEP) para populações sob maior risco de adquirir o vírus da imunodeficiência humana (HIV), no âmbito do Sistema Único de Saúde – SUS. https://bvsms.saude.gov.br/bvs/saudelegis/sctie/2017/prt0021_29_05_2017.html
UNAIDS. (2020). Global HIV & AIDS statistics: fact sheet. https://www.unaids.org/en/resources/fact-sheet
Grinsztejn, B., Hoagland, B., Moreira, R. I., Kallas, E. G., Madruga, J. V., Goulart, S., Leite, I. C., Freitas, L., Martins, L., Torres, T. S., Vasconcelos, R., De Boni, R. B., Anderson, P. L., Liu, A., Luz, P. M., Veloso, V. G., & PrEP Brasil Study Team (2018). Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. The Lancet HIV, 5(3), e136–e145. https://doi.org/10.1016/S2352-3018(18)30008-0
Hipólito, R. L., Oliveira, D. C., Cecilio, H. P. M., Marques, S. C., Flores, P. V. P., Costa, T. L., & Lima, F. O. (2020). Quality of life of people living with HIV and their multifactorial relationships. Research, Society and Development, 9(7), e82973749. https://doi.org/10.33448/rsd-v9i7.3749
Hoagland, B., Moreira, R. I., De Boni, R. B., Kallas, E. G., Madruga, J. V., Vasconcelos, R., Goulart, S., Torres, T. S.,
Marins, L., Anderson, P. L., Luz, P. M., Costa Leite, I. D., Liu, A. Y., Veloso, V. G., Grinsztejn, B., & PrEP Brasil Study TeamClinical Trial Number 01989611 (2017). High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. Journal of the International AIDS Society, 20(1), 21472. https://doi.org/10.7448/IAS.20.1.21472
Evans, C., Bennett, J., Croston, M., Brito-Ault, N., & Bruton, J. (2015). "In reality, it is complex and difficult": UK nurses' perspectives on "treatment as prevention" within HIV care. AIDS Care, 27(6), 753–757. https://doi.org/10.1080/09540121.2014.1002826
Okwundu, C. I., Uthman, O. A., & Okoromah, C. A. (2012). Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. The Cochrane Database of Systematic Reviews, (7), CD007189. https://doi.org/10.1002/14651858.CD007189.pub3
Molina, J. M., Charreau, I., Spire, B., Cotte, L., Pialoux, G., Capitant, C., Tremblay, C., Castro, D. R., & Meyer, L. (2016). On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. Paper presented at the 23rd Conference on Retroviruses and Opportunistic Infections, CROI. EUA.
Oldenburg, C. E., Bärnighausen, T., Harling, G., Mimiaga, M. J., & Mayer, K. H. (2014). Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis. AIDS and Behavior, 18(2), 217–225. https://doi.org/10.1007/s10461-013-0567-0
Bogoch, I. I., Scully, E. P., Zachary, K. C., Yawetz, S., Mayer, K. H., Bell, C. M., & Andrews, J. R. (2014). Patient attrition between the emergency department and clinic among individuals presenting for HIV nonoccupational postexposure prophylaxis. Clinical Infectious Diseases, 58(11), 1618–1624. https://doi.org/10.1093/cid/ciu118
Gupta, G. R., Parkhurst, J. O., Ogden, J. A., Aggleton, P., & Mahal, A. (2008). Structural approaches to HIV prevention. Lancet, 372(9640), 764–775. https://doi.org/10.1016/S0140-6736(08)60887-9
Nordling, L. (2014). Homophobia and HIV research: under siege. Nature, 509: 274-275. https://doi.org/10.1038/509274a
Barp, L. F. G. & Mitjavila, M. R. (2020). O reaparecimento da homossexualidade masculina nas estratégias de prevenção da infecção por HIV: reflexões sobre a implementação da PrEP no Brasil. Physis: Revista de Saúde Coletiva, 30(3), e300319, https://doi.org/10.1590/S0103-73312020300319
Gonçalves, T. R., Costa, A., Sales, M. S., & Leite, H. M. (2020). Prevenção combinada do HIV? Revisão sistemática de intervenções com mulheres de países de média e baixa renda. Ciência & Saúde Coletiva, 25(5), 1897–1912. https://doi.org/10.1590/1413-81232020255.15832018
Marins, L., Torres, T. S., Leite, I., Moreira, R. I., Luz, P. M., Hoagland, B., Kallas, E. G., Madruga, J. V., Liu, A. Y., Anderson, P. L., Grinsztejn, B., & Veloso, V. G. (2019). Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: eesults from the PrEP Brasil Study. PloS One, 14(8), e0221281. https://doi.org/10.1371/journal.pone.0221281
Meireles, J. V. C. & Brito, M. V. (2020). Precocious immunosenescence in HIV infection: effect of chronic viral persistence or antirretroviral therapy? Research, Society and Development, 9(9), e592997436. https://doi.org/10.33448/rsd-v9i9.7436
Mendonça, E. T. M., Araújo, E. C., Botelho, E. P., Polaro, S. H. I., & Gonçalves, L. H. T. (2020). Experience of sexuality and HIV/Aids in the third age. Research, Society and Development, 9(7), e483974256. https://doi.org/10.33448/rsd-v9i7.4256
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ana Victória Butarelo; Cléa Adas Saliba Garbin; Tânia Adas Saliba; Fernando Yamamoto Chiba; Artênio José Ísper Garbin
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
